Bionime Corporation operates within the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Bionime with three other
companies in this sector in TAIWAN :
Genereach Biotechnology Corp
sales of 857.03 million Taiwanese Dollars [US$30.83 million]
of which 69%
Apex Biotechnology Corporation
(2.01 billion Taiwanese Dollars [US$72.13 million]
of which 63%
was Test Strip), and
OK Biotech Co Ltd
(1.48 billion Taiwanese Dollars [US$53.39 million]
of which 100%
was Ok Biotech Co Ltd).
During the first
quarter of 2021, sales at Bionime totalled
463.80 million Taiwanese Dollars .
an increase of 31.2%
from the 353.41 million Taiwanese Dollars in sales at the company during the first quarter of 2020.
This was the biggest same quarter rise in sales at Bionime in the previous 34 quarters.
During the year ended December of 2020, sales at
Bionime were 1.67 billion Taiwanese Dollars (US$60.02 million).
decrease of 23.2%
versus 2019, when the company's sales were 2.17 billion Taiwanese Dollars .
The sales level in 2020 was fairly close to the level five years ago: in 2015, Bionime had sales
of 1.61 billion Taiwanese Dollars .